Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies.
Petzer V, Steiner N, Angelova-Unterberger O, Hetzenauer G, Philipp-Abbrederis K, Willenbacher E, Feistritzer C, Willenbacher W, Rudzki J, Stauder R, Kocher F, Seeber A, Pircher A, Tymoszuk P, Isara C, Egger A, Fux V, Anliker M, Gunsilius E, Nachbaur D, Schmidt S, Wolf D.
Petzer V, et al. Among authors: feistritzer c.
Hemasphere. 2022 Feb 15;6(3):e686. doi: 10.1097/HS9.0000000000000686. eCollection 2022 Mar.
Hemasphere. 2022.
PMID: 35187405
Free PMC article.
No abstract available.